236 results on '"Ho, Gwo-Fuang"'
Search Results
2. Sexual Wellbeing and Supportive Care Needs After Cancer in a Multiethnic Asian Setting: A Qualitative Study
3. A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy
4. First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
5. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
6. Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients
7. Insights on emotional distress following cancer, sources of support and the unmet needs in a setting with limited supportive care services for people living with cancer
8. Working after cancer: in-depth perspectives from a setting with limited employment protection policies
9. Development and evaluation of a sustainable video health education program for newly diagnosed breast cancer patients in Malaysia
10. Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
11. Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
12. Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study.
13. P20-3 CDK1 expression in breast cancer
14. Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122
15. 295 University Malaya Medical Centre experience using VMAT for total body irradiation
16. 12 A home-grown clinical oncology training program to address the shortage of oncologists in Malaysia.
17. Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients
18. A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
19. A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
20. Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology
21. Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.
22. Candida species and oral mycobiota of patients clinically diagnosed with oral thrush
23. Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer
24. Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
25. Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country
26. Sexual Wellbeing and Supportive Care Needs After Cancer in a Multiethnic Asian Setting: A Qualitative Study
27. Quality of Life of Family Caregivers of Cancer Patients in a Developing Nation
28. Cancer-related costs, the resulting financial impact and coping strategies among cancer survivors living in a setting with a pluralistic health system: a qualitative study
29. Sunrise in melanoma management: Time to focus on melanoma burden in Asia
30. Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection
31. Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia
32. A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR).
33. 157 Universiti Malaya's Adoption of Cloud-Based Treatment Planning System for Contouring Education
34. Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
35. Robotic-assisted thermal ablation of liver tumours
36. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients
37. Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country
38. Abstract P2-13-04: Final survival analysis of a phase 3 study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast cancer
39. Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
40. Robot-assisted radiofrequency ablation of primary and secondary liver tumours: early experience
41. EXPLORING UNMET NEEDS FROM AN ONLINE METASTATIC BREAST CANCER SUPPORT GROUP: A QUALITATIVE STUDY
42. Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study
43. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews
44. Mindful gratitude journaling: psychological distress, quality of life and suffering in advanced cancer: a randomised controlled trial
45. Mindful gratitude journaling: psychological distress, quality of life and suffering in advanced cancer: a randomised controlled trial
46. Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
47. Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
48. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes
49. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity
50. Palbociclib in the treatment of recurrent ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.